⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1561234 | 1.00 | — | — | |
| SCHEMBL659682 | 1.00 | — | — | |
| Ethane SCHEMBL1196313 | 0.97 | CYP2C19 (0.59) | — | |
| Hydrochloric Acid SCHEMBL18580994 | 0.97 | — | — | |
| SCHEMBL6377044 | 0.87 | CYP2C19 (0.48) | — | |
| SCHEMBL3361136 | 0.87 | CYP2C19 (0.48) | — | |
| SCHEMBL7271910 | 0.81 | CYP2C19 (0.56) | — | |
| SCHEMBL7524086 | 0.80 | — | — | |
| SCHEMBL7517438 | 0.80 | — | — | |
| SCHEMBL3070137 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12410262-B2 | Peptide conjugates of cytotoxins as therapeutics | Cybrexa 2, Inc. (US) | 2025-09-09 | — | — | US | disclosed |
| US-20240010755-A1 | PEPTIDE CONJUGATES OF CYTOTOXINS AS THERAPEUTICS | Cybrexa 2, Inc. | 2024-01-11 | — | — | US | disclosed |
| US-11634508-B2 | Peptide conjugates of cytotoxins as therapeutics | Cybrexa 2, Inc. (US) | 2023-04-25 | — | — | US | disclosed |
| EP-3997093-A1 | PEPTIDE CONJUGATES OF CYTOTOXINS AS THERAPEUTICS | Cybrexa 2, Inc. (US) | 2022-05-18 | — | — | EP | disclosed |
| CN-114341162-A | Peptide conjugates of cytotoxins as therapeutic agents | 赛博克萨2公司 | 2022-04-12 | — | — | CN | disclosed |
| US-20210009719-A1 | PEPTIDE CONJUGATES OF CYTOTOXINS AS THERAPEUTICS | Cybrexa 2, Inc. | 2021-01-14 | — | — | US | disclosed |
| CN-110066835-B | Application of lipase in resolution of racemic ethyl 2-bromoisovalerate | 浙江工业大学 | 2020-12-25 | — | — | CN | disclosed |
| US-9095565-B2 | Methods for treating blood disorders | PHOENICIA BIOSCIENCES, INC. (US) | 2015-08-04 | — | — | US | disclosed |
| US-9095565-B2 | Methods for treating blood disorders | PHOENICIA BIOSCIENCES, INC. (US) | 2015-08-04 | — | — | US | disclosed |
| US-9095565-B2 | Methods for treating blood disorders | PHOENICIA BIOSCIENCES, INC. (US) | 2015-08-04 | — | — | US | disclosed |
| CN-1964956-A | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | AMGEN (US) | 2007-05-16 | — | — | CN | disclosed |
| EP-1753736-A2 | INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 | Amgen Inc. (US) | 2007-02-21 | — | — | EP | disclosed |
| US-20060142357-A1 | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | AMGEN INC. | 2006-06-29 | — | — | US | disclosed |
| WO-2005116002-A2 | INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 | AMGEN INC. (US) | 2005-12-08 | — | — | WO | disclosed |
| CN-1314906-A | Salts of paroxetine | SMITHKLINE BEECHAM PLC (GB) | 2001-09-26 | — | — | CN | disclosed |
| EP-0728144-B1 | PEPTIDYL COMPOUNDS AND THEIR THERAPEUTIC USE AS INHIBITORS OF METALLOPROTEINASES | DARWIN DISCOVERY LTD (GB) | 2000-01-19 | — | — | EP | disclosed |
| US-5853623-A | Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases | CHIROSCIENCE LIMITED (GB) | 1998-12-29 | — | — | US | disclosed |
| EP-0038617-B1 | DIASTEREOMERS OF AMINO ACID ESTERS, PESTICIDAL COMPOSITIONS INCLUDING THEM AND METHOD OF CONTROLLING PESTS USING THEM | ZOECON CORPORATION (US) | 1983-07-20 | — | — | EP | disclosed |
| EP-0038617-A1 | Diastereomers of amino acid esters, pesticidal compositions including them and method of controlling pests using them | ZOECON CORPORATION (US) | 1981-10-28 | — | — | EP | disclosed |
| US-4260633-A | INSECTICIDES, MITICIDES | ZOECON CORPORATION (US) | 1981-04-07 | — | — | US | disclosed |